These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 8573662

  • 1. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR, Merikangas JR.
    Biol Psychiatry; 1995 Nov 01; 38(9):603-10. PubMed ID: 8573662
    [Abstract] [Full Text] [Related]

  • 2. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P, Pérez J, Alvarez E, Artigas F.
    J Clin Psychopharmacol; 1992 Oct 01; 12(5):309-15. PubMed ID: 1282522
    [Abstract] [Full Text] [Related]

  • 3. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1940-3. PubMed ID: 14574774
    [Abstract] [Full Text] [Related]

  • 4. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 04; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 5. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A, Elliott ES, Watson BD, Treacy J.
    Ann Pharmacother; 2004 Mar 04; 38(3):508. PubMed ID: 14970373
    [No Abstract] [Full Text] [Related]

  • 6. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ, Stewart JW, Nunes EN, Quitkin FM.
    J Clin Psychiatry; 1994 Aug 04; 55(8):336-9. PubMed ID: 8071301
    [Abstract] [Full Text] [Related]

  • 7. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y, Karniel E, Szor H.
    Isr J Psychiatry Relat Sci; 1996 Aug 04; 33(3):211-2. PubMed ID: 9009521
    [No Abstract] [Full Text] [Related]

  • 8. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul 04; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 9. An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
    Krymchantowski AV, Jevoux C, Moreira PF.
    Pain Med; 2010 Jan 04; 11(1):48-52. PubMed ID: 20002594
    [Abstract] [Full Text] [Related]

  • 10. Monoamine oxidase inhibitors.
    Lippmann S.
    Am Fam Physician; 1986 Jul 04; 34(1):113-9. PubMed ID: 3728254
    [Abstract] [Full Text] [Related]

  • 11. An open trial of MAO inhibitors in bulimia.
    Stewart JW, Walsh BT, Wright L, Roose SP, Glassman AH.
    J Clin Psychiatry; 1984 May 04; 45(5):217-9. PubMed ID: 6373746
    [Abstract] [Full Text] [Related]

  • 12. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL, Sunderland T, Cohen RM.
    Psychiatr Clin North Am; 1984 Sep 04; 7(3):549-62. PubMed ID: 6384960
    [Abstract] [Full Text] [Related]

  • 13. Phenelzine and atenolol in social phobia.
    Liebowitz MR, Schneier F, Campeas R, Gorman J, Fyer A, Hollander E, Hatterer J, Papp L.
    Psychopharmacol Bull; 1990 Sep 04; 26(1):123-5. PubMed ID: 2196620
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension.
    Mettimano M, Pichetti F, Fazzari L, Migneco A, Specchia L, Romano Spica V, Savi L.
    Int J Clin Pract; 2000 Sep 04; 54(7):424-8. PubMed ID: 11070565
    [Abstract] [Full Text] [Related]

  • 15. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP, Herbstein J, Damlouji N.
    J Clin Psychiatry; 1985 Jun 04; 46(6):206-9. PubMed ID: 3997787
    [Abstract] [Full Text] [Related]

  • 16. Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
    Liebowitz MR, Gorman JM, Fyer AJ, Campeas R, Levin AP, Sandberg D, Hollander E, Papp L, Goetz D.
    J Clin Psychiatry; 1988 Jul 04; 49(7):252-7. PubMed ID: 3292516
    [Abstract] [Full Text] [Related]

  • 17. Triiodothyronine potentiation of the antidepressant effect of phenelzine.
    Joffe RT.
    J Clin Psychiatry; 1988 Oct 04; 49(10):409-10. PubMed ID: 3170493
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.